U.S. Office REITs Stock News

With the Federal Reserve hinting at possible rate hikes in 2026 and inflation holding at 4.2%, value stocks are back in focus for investors who care about price tags as much as potential. Higher-for-longer rates can reward companies with resilient balance sheets and sensible valuations, while putting pressure on those priced for perfection. This article highlights three value stocks from our screener that are closely exposed to the latest Fed and inflation news. It explains why some investors...

AAON (AAON) raised its 2026 revenue growth outlook to 40% to 45%, citing record backlog, expanding capacity, and improving production execution, particularly at BASX, as key supports for the stock's recent move. See our latest analysis for AAON. The latest guidance upgrade lands on top of strong momentum in AAON stock, with a 90 day share price return of 66.6% and a 1 year total shareholder return of 86.58%. However, the 30 day share price move has been roughly flat, which may hint that...

In recent months, UroGen Pharma resolved a patent dispute with Teva Pharmaceuticals by granting a non-exclusive license for a generic version of Jelmyto starting 15 September 2030, while reporting modest Jelmyto growth and significantly stronger first-quarter sales for its newer therapy, Zusduri. This combination of a long-dated generic entry and early commercial momentum for Zusduri reshapes how investors weigh UroGen’s product concentration and revenue-risk profile. With the Teva...

Insider Selling and Valuation Concerns Put Impinj Stock in Focus Impinj (PI) shares fell 5.0% on June 16, 2026, after renewed attention on valuation, with the stock trading 5.5% above its estimated intrinsic value and recent insider selling totaling US$49.4 million. See our latest analysis for Impinj. The latest drop in Impinj's share price fits into a mixed picture, with a 23.29% 90 day share price return contrasting with a year to date share price decline of 31.35%. At the same time, the 5...

If you are wondering whether Corcept Therapeutics stock is still attractively priced after a strong run, the key question now is how its current share price compares with a reasonable view of fair value. The stock last closed at US$81.75, with returns of 4.6% over the past week, 48.3% over the past month, 114.0% year to date, 14.8% over the past year, 264.0% over three years, and 267.3% over five years. These figures naturally raise questions about how much of the story might already be...

The Fed’s hawkish turn, with rates held at 3.5 to 3.75% and the next move likely a hike, has quickly reshaped expectations for dividend stocks. Higher yields on cash and bonds can pressure income stocks, but solid dividend growth companies with healthy balance sheets can still play a role for investors looking for reliable cash flows and potential income growth. This article looks at three dividend growth stocks from our screener that appear well positioned against this new rate backdrop and...

Wondering if Willis Towers Watson stock is priced attractively today or if the risks outweigh the potential reward? This article breaks down what the current share price might be implying. Willis Towers Watson last closed at US$260.03. While the stock has risen 1.2% over the past month, it is still down 20.3% year to date and 11.6% over the past year, with a gain of 16.1% over three years and 20.4% over five years. These mixed returns sit against an ongoing flow of industry and macro news...

Wondering if Yum China Holdings stock still offers value at current levels, or if the recent moves have already priced in the story? This article walks through what the numbers are saying right now. The share price closed at US$43.28, with returns that declined 1.2% over the past week, 4.8% over the past month, and 10.2% year to date. Over longer periods, the share price has risen 3.5% over the past year and declined 20.9% over three years and 30.0% over five years. These shifts can change...

Global inflation questions, shifting central bank policies and energy price swings have put resilience and reliability at the top of many investors’ wish lists. Aerospace and defense companies sit at the crossroads of government spending, long-term contracts and critical infrastructure, which can offer a different risk and return profile compared with more cyclical areas of the market. This Aerospace And Defense screener filters for companies that manufacture or provide services to these...

Earlier in June 2026, Waste Connections announced an 11.1% increase in its dividend, highlighting management’s emphasis on returning more cash to shareholders while running a large North American waste management network. The dividend hike comes even as the company faces signs of slowing demand and pressure on profitability, underscoring a tension between income-focused capital returns and operational headwinds. We’ll now examine how this sizable dividend increase, set against concerns about...

Earlier in June 2026, GH Research PLC reported full Phase 2a results for its inhaled Mebufotenin (GH001) in postpartum depression, showing rapid remission in all 10 patients, improved maternal functioning, and a favorable safety profile, with findings published in The Journal of Clinical Psychiatry and highlighted at the upcoming CINP 2026 congress. An additional practical insight from the trial was that drug levels in breast milk supported only a brief interruption of breastfeeding around...

Pomerantz LLP is investigating Futu Holdings (NasdaqGM:FUTU) after a Reuters report that Chinese regulators may penalize the broker for soliciting clients without an onshore license, bringing regulatory risk into focus. See our latest analysis for Futu Holdings. The investigation comes after a difficult period for Futu Holdings, with the share price down 46.2% year to date and 33.6% over 90 days. However, the three year total shareholder return is 152.7%, suggesting long term holders have...

John Wiley & Sons (WLY) closed FY 2026 with fourth quarter revenue of US$447.9 million and basic EPS of US$2.65, supported by trailing twelve month EPS of US$4.22 on revenue of US$1.68 billion. Over recent periods, the company has seen quarterly revenue move from US$404.6 million in FY 2025 Q3 to US$442.6 million in FY 2025 Q4 and then to US$447.9 million in FY 2026 Q4. Basic EPS shifted from a loss of US$0.43 in FY 2025 Q3 to US$1.27 in FY 2025 Q4 and US$2.65 in FY 2026 Q4, alongside...

In recent sessions, Marathon Digital Holdings, Inc. (MARA) reported an expected quarterly EPS of US$0.44 loss, while moving further into artificial intelligence by deploying AI inference racks and investing in a high-performance computing data center business. The company also sold 15,133 Bitcoin to reinforce its balance sheet amid industry-wide pressure on mining profitability, underscoring a meaningful shift in how it balances digital assets against new infrastructure growth. Next, we’ll...

In recent days, analysts highlighted that TriMas holds a Zacks Rank #2 (Buy) and a Momentum Style Score of B, supported by upward earnings estimate revisions and recent outperformance versus its industry and the broader market. This renewed analyst attention underscores how improving earnings expectations and momentum indicators can materially influence how investors assess TriMas' near-term prospects. We’ll now examine how the upgraded earnings estimates and momentum profile may influence...

Recent research updates highlighted that Ternium S.A. received a favorable Zacks Rank #2 (Buy) and a Momentum Score of B, supported by upward earnings estimate revisions and stronger momentum signals relative to other steel producers. Analysts also pointed out that Ternium’s improving earnings outlook and valuation metrics have made it stand out versus peers like Commercial Metals, reinforcing its position as a preferred steel producer in current coverage. We’ll now examine how these upward...

Enovis stock reaction to the new Spinamic scoliosis brace launch Enovis (ENOV) has drawn fresh investor attention after launching the DonJoy Spinamic Hybrid Scoliosis Brace, a hybrid rigid and soft brace for adolescent idiopathic scoliosis that is now available in the United States. See our latest analysis for Enovis. For context, Enovis shares have pulled back over the year, with the year to date share price return down 18.6% and the 1 year total shareholder return down 30.1%, so the recent...

Dow stock reacts to new water sustainability agreement Dow (DOW) is in focus after Xylem Inc. agreed to design, build and operate advanced water treatment and reuse systems at Dow’s Fort Saskatchewan industrial complex in Alberta, Canada. See our latest analysis for Dow. Despite the sustainability focus of the new Xylem agreement and recent conference appearances, Dow’s share price has eased in the short term, with a 30-day share price return down 14.9%, while the 1-year total shareholder...

Recently, Himax Technologies drew attention when GuruFocus assessed the stock as significantly overvalued relative to its GF Value™-based intrinsic estimate, flagging elevated risk for investors. An absence of insider share transactions over the past three months adds an extra dimension to the market’s response to these overvaluation concerns. Next, we’ll examine how GuruFocus’s overvaluation warning may influence Himax Technologies’ existing investment narrative around growth, margins, and...

PulteGroup (PHM) has drawn investor attention after recent share price moves, with the stock up 13.3% over the past month and 6.6% in the past 3 months, outpacing its shorter term returns. See our latest analysis for PulteGroup. Looking beyond the recent move, PulteGroup’s 1-year total shareholder return of 27.38% and 3-year total shareholder return of 70.49% indicate that the latest share price strength around $124.76 continues a broader period of positive momentum. If you want to see what...

Brookdale Senior Living Inc. recently reported its May 2026 operating results, highlighting a year-over-year increase of 250 basis points in weighted average occupancy to 82.5% and sequential growth consistent with seasonal patterns. The company also disclosed that same community weighted average occupancy reached 82.9%, suggesting broad-based improvement across its existing senior living portfolio rather than gains driven solely by newer communities. Next, we’ll consider how this...

Grand Canyon Education (LOPE) stock has drawn investor attention after recent trading left shares down about 10% over the past month and about 12% over the past 3 months. This has sharpened the focus on fundamentals. See our latest analysis for Grand Canyon Education. At the latest share price of $144.39, Grand Canyon Education has seen short term momentum fade, with the 7 day share price return down 4.19% and the 1 month share price return down 10.37%. The 1 year total shareholder return is...

American Assets Trust (AAT) has drawn fresh attention after recent trading pushed the stock to a one-month return of about 17% and an approximate 29% gain over the past 3 months. See our latest analysis for American Assets Trust. At the latest share price of $24.40, American Assets Trust has had a strong run in recent months, with a 30-day share price return of 17.5% and a 90-day share price return of 28.9%, while the 1-year total shareholder return of 26.2% and 3-year total shareholder...

When worries grow about political pressure on the Federal Reserve and the risk of higher Treasury yields, many investors start looking for real assets and reliable income. The Inflation-Resistant Real Asset Stocks screener focuses on companies with solid balance sheets and dividend payouts that may help cushion the impact of rising borrowing costs and market stress. In this article, three stocks from that screener, each exposed in different ways to the current Fed credibility debate, are...